QA: Altrazeal Life Sciences Inc in us_pharma/2014

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001168220_2015_Altrazeal_Life_Sciences_Inc.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001168220, Altrazeal Life Sciences Inc

  xvar xval
0 AssetsCurrent 1,815,999
1 IntangibleAssetsNetIncludingGoodwill 3,195,689
2 PropertyPlantAndEquipmentNet 432,110
3 remainder_Assets 18,069
4 LiabilitiesCurrent 1,868,772
5 LiabilitiesNoncurrent 839,174
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 1,694,336
9 ResearchAndDevelopmentExpense 772,320
10 remainder_Expenses 1,330,064
11 remainder_Revenues 773,908
12 remainder_NetIncome 5,956,336
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 5,461,867
1 Liabilities 2,707,946
2 Expenses 3,796,720
3 Revenues 773,908
4 StockholdersEquity 2,753,921
5 NetIncome 2,933,524
6 ComprehensiveNetIncome 2,933,524
7 BaseVar 9,348,388
8 EconomicCapitalRatiobeforeLimitedLiability 2.19
9 EconomicCapitalRatio 3.15

Edgar->Model Mapping

Feature Distribution

Change over Time